Autologous platelets as a source of proteins for healing and tissue regeneration
暂无分享,去创建一个
Paquita Nurden | Eduardo Anitua | P. Nurden | A. Nurden | E. Anitua | Isabel Andia | Alan T Nurden | Bruno Ardanza | I. Andia | B. Ardanza
[1] Reinhold Förster,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.
[2] C. Peterson,et al. Plasminogen Activator Inhibitor Type 1 Promotes the Self-association of Vitronectin into Complexes Exhibiting Altered Incorporation into the Extracellular Matrix* , 2002, The Journal of Biological Chemistry.
[3] K. Preissner,et al. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[4] K. Schrör,et al. Platelet surface membranes are highly mitogenic for coronary artery smooth muscle cells--A novel mechanism for sustained proliferation after vessel injury? , 1999, Biochemical and biophysical research communications.
[5] M. Nasu,et al. Bioactivity of the Vascular Endothelial Growth Factor Trapped in Fibrin Clots: Production of IL-6 and IL-8 in Monocytes by Fibrin Clots , 2001, Pathophysiology of Haemostasis and Thrombosis.
[6] M. Karpatkin,et al. Risks of using platelet rich plasma gel. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[7] Brian Savage,et al. Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow , 1998, Cell.
[8] S. Bhanot,et al. Current Applications of Platelet Gels in Facial Plastic Surgery , 2002, Facial plastic surgery : FPS.
[9] A. Weyrich,et al. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. , 2002, Circulation.
[10] P. Branemark,et al. Response of bone marrow to titanium implants: osseointegration and the establishment of a bone marrow-titanium interface in mice. , 1993, The International journal of oral & maxillofacial implants.
[11] D. Margolis,et al. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. , 2001, Diabetes care.
[12] Ying Yu,et al. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. , 2003, American journal of physiology. Cell physiology.
[13] Hiroshi Tanaka,et al. Effect of platelet‐derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats , 1995, Journal of cellular physiology.
[14] Gideon A. Rodan,et al. Control of osteoblast function and regulation of bone mass , 2003, Nature.
[15] D. Dixon,et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis , 2001, The Journal of cell biology.
[16] J. Karp,et al. Effect of Platelet Releasate on Bone Cell Migration and Recruitment In Vitro , 2003, The Journal of craniofacial surgery.
[17] F. Rendu,et al. The platelet release reaction: granules' constituents, secretion and functions , 2001, Platelets.
[18] W. Siess,et al. Platelet signal transduction mechanisms induced by eicosanoids. , 1992, Eicosanoids.
[19] I. Chaiken,et al. Tissue factor regulates plasminogen binding and activation. , 1998, Blood.
[20] K. Wakabayashi,et al. Platelet‐Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory Factor , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] R. McEver. P-selectin and PSGL-1: Exploiting Connections Between Inflammation and Venous Thrombosis , 2002, Thrombosis and Haemostasis.
[22] E. Ruoslahti,et al. Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain* , 2000, The Journal of Biological Chemistry.
[23] J. J. de Obarrio,et al. The use of autologous growth factors in periodontal surgical therapy: platelet gel biotechnology--case reports. , 2000, The International journal of periodontics & restorative dentistry.
[24] J. Krijgsveld,et al. Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines* , 2000, The Journal of Biological Chemistry.
[25] K. Hatakeyama,et al. Tissue Factor Induces Migration of Cultured Aortic Smooth Muscle Cells , 1996, Thrombosis and Haemostasis.
[26] J. Wiltfang,et al. Different preparation methods to obtain platelet components as a source of growth factors for local application , 2001, Transfusion.
[27] Y. Nemerson,et al. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. , 2002, Blood.
[28] E. Allan,et al. Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.
[29] R. Hynes,et al. Integrin receptors are required for cell survival and proliferation during development of the peripheral glial lineage. , 2001, Developmental biology.
[30] R. Haas,et al. Influence of platelet-rich plasma on osseous healing of dental implants: a histologic and histomorphometric study in minipigs. , 2003, The International journal of oral & maxillofacial implants.
[31] H. Klüter,et al. Preparation of autologous platelets for the ophthalmologic treatment of macular holes , 1999, Transfusion.
[32] M. Lind,et al. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. , 1998, Acta orthopaedica Scandinavica. Supplementum.
[33] M. Tischler. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. , 2002, The New York state dental journal.
[34] J. Wozney,et al. Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .
[35] J. Badimón,et al. Membrane-associated CD40L and sCD40L in atherothrombotic disease , 2003, Thrombosis and Haemostasis.
[36] S. Rafii,et al. Trophic Effects of Platelets on Cultured Endothelial Cells are Mediated by Platelet-associated Fibroblast Growth Factor-2 (FGF-2) and Vascular Endothelial Growth Factor (VEGF) , 2002, Thrombosis and Haemostasis.
[37] M. Wolzt,et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[38] W. Giannobile,et al. Gene Transfer and Expression of Platelet-derived Growth Factors Modulate Periodontal Cellular Activity , 2001, Journal of dental research.
[39] C. Heldin,et al. Involvement of platelet-derived growth factor in disease: development of specific antagonists. , 2001, Advances in cancer research.
[40] E. Wagner,et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.
[41] G. Burnstock. Purinergic Signaling and Vascular Cell Proliferation and Death , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[42] G. Murrell,et al. The Roles of Growth Factors in Tendon and Ligament Healing , 2003, Sports medicine.
[43] T. Orfeo,et al. Osteonectin in matrix remodeling. A plasminogen-osteonectin-collagen complex. , 1994, The Journal of biological chemistry.
[44] J. Meijers,et al. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. , 2003, Blood.
[45] J. Romashkova,et al. NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.
[46] Patrick André,et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. , 2002, Circulation.
[47] K. Preissner,et al. Molecular Interactions and Functional Interference between Vitronectin and Transforming Growth Factor-β , 2002, Laboratory Investigation.
[48] E. Anitua. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. , 1999, The International journal of oral & maxillofacial implants.
[49] M. Broberg,et al. GpIIb/IIIa is the main receptor for initial platelet adhesion to glass and titanium surfaces in contact with whole blood. , 2002, Journal of Laboratory and Clinical Medicine.
[50] P. Carmeliet,et al. Role of tissue factor in embryonic blood vessel development , 1996, Nature.
[51] G. FitzGerald,et al. Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway* , 1999, The Journal of Biological Chemistry.
[52] H. Plosker,et al. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. , 2001, Plastic and reconstructive surgery.
[53] Nathan E. Carlson,et al. Platelet-rich plasma: clinical applications in dentistry. , 2002, Journal of the American Dental Association.
[54] M. Cerletti,et al. Growth Factor-Dependent Proliferation and Invasion of Muscle Satellite Cells Require the Cell-Associated Fibrinolytic System , 2002, Biological chemistry.
[55] J. Vane. Back to an Aspirin a Day? , 2002, Science.
[56] P. Sheridan,et al. Is platelet-rich plasma the perfect enhancement factor? A current review. , 2003, The International journal of oral & maxillofacial implants.
[57] A. Verin,et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. , 2001, The Journal of clinical investigation.
[58] D. M. Green,et al. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. , 1997, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[59] M. Gimbrone,et al. A role for Smad6 in development and homeostasis of the cardiovascular system , 2000, Nature Genetics.
[60] Andreas Peschel,et al. Chemokines Meet Defensins: the Merging Concepts of Chemoattractants and Antimicrobial Peptides in Host Defense , 2002, Infection and Immunity.
[61] I. Mujika,et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. , 2003, Medicine and science in sports and exercise.
[62] D. Monroe,et al. Platelets and thrombin generation. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[63] K. Ikeda,et al. Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells* , 1998, The Journal of Biological Chemistry.
[64] T. Grosser,et al. Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2 , 2002, Science.
[65] A. Sahni,et al. FGF‐2 but not FGF‐1 binds fibrin and supports prolonged endothelial cell growth , 2003, Journal of thrombosis and haemostasis : JTH.
[66] D. Buchbinder,et al. Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[67] G. Gronowicz,et al. Integrin-mediated signaling in osteoblasts on titanium implant materials. , 2000, Journal of biomedical materials research.
[68] M. Slater,et al. Involvement of platelets in stimulating osteogenic activity , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[69] M E Bolander,et al. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.
[70] P. Nurden,et al. Immunolocalization of P2Y1 and TPα Receptors in Platelets Showed a Major Pool Associated with the Membranes of α-Granules and the Open Canalicular System , 2003 .
[71] E. Canalis,et al. Complex pattern of insulin‐like growth factor binding protein expression in primary rat osteoblast enriched cultures: Regulation by prostaglandin E2, growth hormone, and the insulin‐like growth factors , 1994, Journal of cellular physiology.
[72] F. Karreth,et al. Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. , 2002, Bone.
[73] D. Tziafas,et al. Role of exogenous TGF-beta in induction of reparative dentinogenesis in vivo. , 1998, European journal of oral sciences.
[74] A. Lansdown. Calcium: a potential central regulator in wound healing in the skin , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[75] Z. Jing,et al. Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts. , 2000, Cytokine.
[76] A. Cullinane,et al. Effects of autologous platelet concentrate and serum on retinal wound healing in an animal model , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[77] E. Spencer,et al. Characterisation of insulin-like growth factor-binding protein-3 binding to a novel receptor on human platelet membranes. , 2001, The Journal of endocrinology.
[78] K. Ley,et al. Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury , 2002, Circulation.
[79] K. Yoshikawa,et al. Cutaneous Wound Healing: An Update , 2001, The Journal of dermatology.
[80] G. Hafner,et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. , 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[81] F. Nociti,et al. Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs. , 2000, Implant dentistry.
[82] R. Marx,et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[83] A. Beaulieu,et al. Human plasma fibronectin potentiates the mitogenic activity of platelet‐derived growth factor and complements its wound healing effects , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[84] A. Bikfalvi,et al. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. , 2002, Cancer research.
[85] R. Bareille,et al. Effect of 1,25(OH)2D3 on bone morphogenetic protein‐3 mRNA expression , 1999, Journal of cellular biochemistry.
[86] G. Giannini,et al. The Role of Autologous Fibrin-Platelet Glue in Plastic Surgery: A Preliminary Report , 2002, The International journal of artificial organs.
[87] C. Gemmell,et al. Platelet interactions with titanium: modulation of platelet activity by surface topography. , 2001, Biomaterials.
[88] D. Ory,et al. A Glanzmann’s mutation in β3 integrin specifically impairs osteoclast function , 2001 .
[89] J. Müller,et al. Effects of fibrin glue and growth factors released from platelets on abdominal hernia repair with a resorbable PGA mesh: experimental study. , 1999, The Journal of surgical research.
[90] P. Nurden,et al. Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport. , 1999, Blood.
[91] G. Lowery,et al. Use of autologous growth factors in lumbar spinal fusion. , 1999, Bone.
[92] J. Wozney,et al. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. , 1999, Journal of periodontology.
[93] J. Sahel,et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. , 1999, Ophthalmology.
[94] M. Bryckaert,et al. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. , 2002, Blood.
[95] E. Farrior,et al. Recovery from deep-plane rhytidectomy following unilateral wound treatment with autologous platelet gel: a pilot study. , 2001, Archives of facial plastic surgery.
[96] L. Ignarro,et al. Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[97] B. Engelmann,et al. Platelet ADP receptors contribute to the initiation of intravascular coagulation. , 2004, Blood.
[98] G. Karsenty,et al. The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.
[99] M. Selsted,et al. Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.
[100] J. Palmblad,et al. Angiogenesis Research: Guidelines for Translation to Clinical Application , 2001, Thrombosis and Haemostasis.
[101] E. Tuddenham,et al. Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts , 2003, Journal of thrombosis and haemostasis : JTH.
[102] H. Ueno,et al. Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells. , 2003, Blood.
[103] S. Atri,et al. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. , 1990, Surgery.
[104] J. Hatzfeld,et al. Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors. , 1993, Blood.
[105] J. Jansen,et al. Mandibular reconstruction: a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. , 2002, International journal of oral and maxillofacial surgery.
[106] D. Camerini,et al. Platelet Chemokines and Chemokine Receptors: Linking Hemostasis, Inflammation, and Host Defense , 2003, Microcirculation.
[107] R. Timpl,et al. Structure and Function of Collagen‐Derived Endostatin Inhibitors of Angiogenesis , 2002, IUBMB life.
[108] F. Gilsanz,et al. Treatment of leg ulcers in β‐thalassaemia intermedia: use of platelet‐derived wound healing factors from the patient's own platelets , 2001, British Journal of Haematology.